Fig. 6From: Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironmentAnalysis of genetic alteration of CXC chemokine in cervical cancer. a CXC chemokines’ mutation analysis in cervical cancer (cBioPortal). b The overall survival curve analysis of the altered group and unaltered group (p = 0.895). c The disease-free survival curve analysis of the altered group and unaltered group (p = 0.233). d The progress-free survival curve analysis of the altered group and unaltered group (p = 0.175)Back to article page